Horizon Therapeutics to Present at UBS Global Life Sciences Conference
Horizon Therapeutics to Present at UBS Global Life Sciences Conference
Horizon Therapeutics to Present at UBS Global Life Sciences Conference
09/19/08
Horizon Therapeutics to Present at UBS Global Life Sciences ConferencePALO ALTO, Calif., September 19, 2008 - Horizon Therapeutics, Inc., a privately held biopharmaceutical company, announced today that it will present a corporate overview at the UBS Global Life Sciences Conference in New York on Thursday, September 25 at 1:30 p.m. ET at the Grand Hyatt Hotel.
About Horizon Therapeutics
Horizon Therapeutics, Inc. is a late-stage biopharmaceutical company focused on the development and commercialization of therapies for the treatment of mild-to-moderate pain and arthritis. Horizon's clinical portfolio includes innovative combination therapies in early- and late-stage development that are designed to improve safety, efficacy and patient compliance. For more information about the company and its products, please visit www.horizontherapeutics.com.
Contact:
Geoff Curtis
WeissComm Partners, Inc.
312-284-4701
gcurtis@wcpglobal.com